Dr Tracey Mynott Presents at TRI Science Business Inspiration Series
Dr Tracey Mynott Presents at TRI Science Business Inspiration Series
Sydney, Nov 3, 2017 AEST (ABN Newswire) - Anatara Lifesciences (ASX:ANR) CSO, Dr Tracey Mynott, was recently invited to present at the Translational Research Institute's (TRI) Science Business Inspiration Series. The series was launched with Session 1 "The whole journey: from idea to reality". Through her presentation, Tracey shared her personal journey - translating core research about pineapple roots and piglet gut health - to her current status as CSO of a publicly listed company, which is intent on changing the livestock industry globally.

To read more, please visit:
http://www.abnnewswire.net/lnk/713SA081


About Anatara Lifesciences Ltd

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) develops and aims to partner non-antibiotic, oral products for gastrointestinal diseases in animals and humans where there is significant unmet need and large market opportunity. In May 2018, Anatara granted an exclusive licence to the leading global animal health company, Zoetis Inc., for the worldwide development, manufacturing, distribution and marketing of its lead product Detach as a non-antibiotic approach to aid in the control of diarrhoeal disease (known as scour) in livestock and in horses. Anatara is now focused on developing its human product pipeline for gastrointestinal health applications. For more information, please visit www.anataralifesciences.com.

    


Contact

Investor inquiries:
Dr Mel Bridges
Chairman & CEO
Anatara Lifesciences
Phone: +61-413-051-600
Email: mbridges@anataralifesciences.com

Media inquiries:
Jane Lowe
IR Department
Phone: +61-411-117-774
Email: jane.lowe@irdepartment.com.au


Related Companies

Anatara Lifesciences Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 31) (Last 30 Days: 120) (Since Published: 2983) 
ANALYTICS: LOGIN HERE

Anatara Lifesciences Ltd NEWS: RECENT VISITS (5356)

Research Report

Social Media